Literature DB >> 7491183

Positive thyroid cancer scintigraphy using 99Tcm-tetrofosmin (Myoview): a preliminary report.

J Nĕmec1, O Nývltová, M Preiningerová, P Vlcek, P Racek, Z Novák, T Blazek, J Zimák.   

Abstract

99Tcm-tetrofosmin imaging was performed in 23 thyroid cancer patients and compared with whole-body 131I scans, neck ultrasonography and plasma thyroglobulin levels. Of 22 patients with differentiated thyroid cancer, 8 showed identical images on 131I scan and tetrofosmin; 1 patient with medullary cancer had identical images with 99Tcm-DMSA and 99Tcm-tetrofosmin, the findings being confirmed by sonography. The potential usefulness of 99Tcm-tetrofosmin imaging in the follow-up of thyroid cancers is discussed.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7491183     DOI： 10.1097/00006231-199508000-00012

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN： 0143-3636            Impact factor:   1.690


  3 in total

1.  Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans.

Authors:  M Klain; S Maurea; A Cuocolo; A Colao; L Marzano; G Lombardi; M Salvatore
Journal:  Eur J Nucl Med       Date:  1996-12

2.  Detection of a large substernal goiter during Tc-99m tetrofosmin cardiac SPECT imaging.

Authors:  G C Ravizzini; S E Farnsworth; R A Pagnanelli; S Borges-Neto
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

3.  Positive thyroid cancer scintigraphy using technetium-99m methoxyisobutylisonitrile.

Authors:  J Nĕmec; O Nývltová; T Blazek; P Vlcek; P Racek; Z Novák; M Preiningerová; M Hubácková; M Krízo; J Zimák; R Bílek
Journal:  Eur J Nucl Med       Date:  1996-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.